Bio-Techne Corp
NASDAQ:TECH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bio-Techne Corp
NASDAQ:TECH
|
US |
|
G
|
Grenergy Renovables SA
XMUN:5GR
|
ES |
|
A
|
Allstate Corp
XMUN:ALS
|
US |
|
A
|
Anheuser-Busch Inbev SA
XMUN:1NBA
|
BE |
|
H
|
HeidelbergCement AG
XHAM:HEI
|
DE |
|
W
|
Wells Fargo & Co
XMUN:NWT
|
US |
|
B
|
BlackRock Inc
F:BLQA
|
US |
Wall St Price Targets
TECH Price Targets Summary
Bio-Techne Corp
According to Wall Street analysts, the average 1-year price target for TECH is 65.35 USD with a low forecast of 49.49 USD and a high forecast of 82.95 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TECH's stock price target?
Price Target
65.35
USD
According to Wall Street analysts, the average 1-year price target for TECH is 65.35 USD with a low forecast of 49.49 USD and a high forecast of 82.95 USD.
What is the Revenue forecast for Bio-Techne Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 5%.
What is the Gross Profit forecast for Bio-Techne Corp?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 4 years is 7%.
What is the Operating Income forecast for Bio-Techne Corp?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 4 years is 18%.
What is the Pre-Tax Income forecast for Bio-Techne Corp?
Projected CAGR
68%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -4%. The projected CAGR for the next 3 years is 68%.
What is the Net Income forecast for Bio-Techne Corp?
Projected CAGR
53%
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 4 years is 53%.
